Arabian International Healthcare Holding Valuation
Is 9530 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 4/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 9530?
Other financial metrics that can be useful for relative valuation.
|What is 9530's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does 9530's PE Ratio compare to its peers?
|9530 PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
2230 Saudi Chemical Holding
9544 Future Care Trading
4014 Scientific and Medical Equipment House
9518 Canadian General Medical Center Complex
9530 Arabian International Healthcare Holding
Price-To-Earnings vs Peers: 9530 is good value based on its Price-To-Earnings Ratio (14.4x) compared to the peer average (29.3x).
Price to Earnings Ratio vs Industry
How does 9530's PE Ratio compare vs other companies in the Asian Healthcare Industry?
Price-To-Earnings vs Industry: 9530 is good value based on its Price-To-Earnings Ratio (14.4x) compared to the Asian Healthcare industry average (17.2x)
Price to Earnings Ratio vs Fair Ratio
What is 9530's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||14.4x|
|Fair PE Ratio||n/a|
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 9530's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of 9530 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 9530 (SAR40.8) is trading below our estimate of fair value (SAR59.47)
Significantly Below Fair Value: 9530 is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.